GRAHAM BRASWELL BIOTECHNOLOGIES Trademark

Trademark Overview


On Tuesday, June 21, 2022, a trademark application was filed for GRAHAM BRASWELL BIOTECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the GRAHAM BRASWELL BIOTECHNOLOGIES trademark a serial number of 97469150. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 13, 2024. This trademark is owned by Graham Braswell Biotechnologies Inc.. The GRAHAM BRASWELL BIOTECHNOLOGIES trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services, namely, providing in-clinic hemodialysis, at-home peritoneal dialysis, and at-home hemodialysis services related to chronic kidney disease and end-stage renal disease; medical and surgical center services, namely, providing medical services and hospital services for the treatment of chronic kidney disease and end-stage renal disease

Medical devices and apparatus, namely, inflation devices for balloon catheters, drug-coated medical balloons, dialysis catheters, covered stents, synthetic stent grafts, thrombectomy devices, thrombolysis devices, endovascular fistula creation devices, and surgical devices for surgical fistula creation and kidney transplant; all of the foregoing to be used to treat end-stage kidney disease via hemodialysis or peritoneal dialysis
graham braswell biotechnologies

General Information


Serial Number97469150
Word MarkGRAHAM BRASWELL BIOTECHNOLOGIES
Filing DateTuesday, June 21, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesMedical services, namely, providing in-clinic hemodialysis, at-home peritoneal dialysis, and at-home hemodialysis services related to chronic kidney disease and end-stage renal disease; medical and surgical center services, namely, providing medical services and hospital services for the treatment of chronic kidney disease and end-stage renal disease
NOT AVAILABLE"BIOTECHNOLOGIES"
Goods and ServicesMedical devices and apparatus, namely, inflation devices for balloon catheters, drug-coated medical balloons, dialysis catheters, covered stents, synthetic stent grafts, thrombectomy devices, thrombolysis devices, endovascular fistula creation devices, and surgical devices for surgical fistula creation and kidney transplant; all of the foregoing to be used to treat end-stage kidney disease via hemodialysis or peritoneal dialysis

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, March 11, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGraham Braswell Biotechnologies Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10002

Party NameGraham Braswell Biotechnologies Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10002

Trademark Events


Event DateEvent Description
Friday, June 24, 2022NEW APPLICATION ENTERED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 22, 2022ASSIGNED TO EXAMINER
Wednesday, August 17, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 17, 2022NON-FINAL ACTION E-MAILED
Wednesday, August 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 11, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, March 11, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, March 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, March 11, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, March 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023SOU EXTENSION 1 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU EXTENSION 2 FILED
Friday, June 14, 2024SOU EXTENSION 2 GRANTED